Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Person

Peter Forsell

Tracked across 2 events · 38 articles · First seen Aug 14, 2026 · Last active Sep 08, 2026

Sentiment
42
Attention
4
Events
2
Relationships
4
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 85
Regulatory
Implantica AG, a Liechtenstein-based medtech company, received Premarket Approval (PMA) from the U.S. United States — Food and Drug Administration (FDA) for its RefluxStop device, an implantable treatment for gastroesophageal reflux disease (GERD). The approval,…
Impact: Peter Forsell, CEO and founder, is the key executive driving the company's strategy and public communications around the FDA approval and U.S. launch.
Aug 20, 2026 · 32 articles
0 0
Business
Impact: Peter Forsell, CEO of Implantica, is scheduled to speak at the Q2 2026 presentation, representing the company's leadership and discussing results.
Aug 14, 2026 · 6 articles
Implantica ceo and founder ↔ Peter Forsell Peter Forsell is the founder and current CEO of Implantica, a medical technology
Implantica ↔ Peter Forsell
ERGEN INTELLIGENCE
Track Peter Forsell live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.